Erythroplasia of Queyrat
- 2 June 1975
- journal article
- research article
- Published by American Medical Association (AMA)
- Vol. 232 (9) , 934-937
- https://doi.org/10.1001/jama.1975.03250090024012
Abstract
Three patients with biopsy-confirmed erythroplasia of Queyrat were treated with topically applied fluorouracil. The lesions cleared completely, and recurrence-free follow-up periods ranged from 20 to 60 months. There were normal histological findings in posttreatment biopsy specimens in two of the patients. A literature review yielded five additional cases successfully treated with fluorouracil applied topically. Patients with histologically confirmed erythroplasia of Queyrat should be afforded treatment with topically applied fluorouracil, as results appear to be superior to those of surgical or radiological treatment, with less morbidity. (JAMA232:934-937, 1975)Keywords
This publication has 6 references indexed in Scilit:
- Erythroplasia of Queyrat.A clinicopathologic and histochemical studyCancer, 1973
- Erythroplasia of Queyrat Treated with Topical 5-FluorouracilJournal of Urology, 1969
- Bowenoid Conditions of the Skin: Treatment with Topical 5–FluorouracilSouthern Medical Journal, 1967
- Erythroplasia of QueyratJournal of Urology, 1953
- The Erythroplasia of Queyrat: Two Case ReportsJournal of Urology, 1950
- Erythroplasia of Queyrat: Report of a CaseJournal of Urology, 1948